Paving New Roads for CARs

被引:25
作者
Hyrenius-Wittsten, Axel [1 ,2 ]
Roybal, Kole T. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[2] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA
[3] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
来源
TRENDS IN CANCER | 2019年 / 5卷 / 10期
基金
瑞典研究理事会;
关键词
CHIMERIC ANTIGEN RECEPTOR; MODIFIED T-CELLS; 4-1BB COSTIMULATION; LYMPHOCYTES; SUPERIOR; DOMAIN; SURVIVAL; IMMUNOTHERAPY; RECOGNITION; ACTIVATION;
D O I
10.1016/j.trecan.2019.09.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chimeric antigen receptor (CAR)-T cell therapy has had unprecedented impact in the treatment of hematological malignancies with few therapeutic options. However, it is clear that new strategies to enhance CAR-T cell function in solid tumors are needed to make these living drugs widely applicable. The roadblock in solid tumors has led to a surge in the development of strategies to enhance CAR-T cells through advanced receptor design, new tumor sensing mechanisms, coexpression of genes that improve T cell function or stimulate tumor immunity, and precise genome editing. Here we provide an overview of the current state of the art in CAR-T cell engineering and a framework for the development of next-generation immune cell therapies with synthetic biology.
引用
收藏
页码:583 / 592
页数:10
相关论文
共 71 条
[1]   Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains [J].
Alabanza, Leah ;
Pegues, Melissa ;
Geldres, Claudia ;
Shi, Victoria ;
Wiltzius, Jed J. W. ;
Sievers, Stuart A. ;
Yang, Shicheng ;
Kochenderfer, James N. .
MOLECULAR THERAPY, 2017, 25 (11) :2452-2465
[2]   CD3ζ based chimeric antigen receptors mediate T cell activation via cis-and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy [J].
Bridgeman, J. S. ;
Ladell, K. ;
Sheard, V. E. ;
Miners, K. ;
Hawkins, R. E. ;
Price, D. A. ;
Gilham, D. E. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (02) :258-267
[3]   The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3ζ Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex [J].
Bridgeman, John S. ;
Hawkins, Robert E. ;
Bagley, Steve ;
Blaylock, Morgan ;
Holland, Mark ;
Gilham, David E. .
JOURNAL OF IMMUNOLOGY, 2010, 184 (12) :6938-6949
[4]   Fine-tuning Tumor Immunity with Integrin Trans-regulation [J].
Cantor, Joseph M. ;
Rose, David M. ;
Slepak, Marina ;
Ginsberg, Mark H. .
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (06) :661-667
[5]   Differential Role of Th1 and Th2 Cytokines in Autotoxicity Driven by CD19-Specific Second-Generation Chimeric Antigen Receptor T Cells in a Mouse Model [J].
Cheadle, Eleanor J. ;
Sheard, Victoria ;
Rothwell, Dominic G. ;
Bridgeman, John S. ;
Ashton, Garry ;
Hanson, Vivien ;
Mansoor, A. Wasat ;
Hawkins, Robert E. ;
Gilham, David E. .
JOURNAL OF IMMUNOLOGY, 2014, 192 (08) :3654-3665
[6]   A compound chimeric antigen receptor strategy for targeting multiple myeloma [J].
Chen, K. H. ;
Wada, M. ;
Pinz, K. G. ;
Liu, H. ;
Shuai, X. ;
Chen, X. ;
Yan, L. E. ;
Petrov, J. C. ;
Salman, H. ;
Senzel, L. ;
Leung, E. L. H. ;
Jiang, X. ;
Ma, Y. .
LEUKEMIA, 2018, 32 (02) :402-412
[7]   Molecular mechanisms of T cell co-stimulation and co-inhibition [J].
Chen, Lieping ;
Flies, Dallas B. .
NATURE REVIEWS IMMUNOLOGY, 2013, 13 (04) :227-242
[8]   Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial [J].
Chiocca, E. Antonio ;
Yu, John S. ;
Lukas, Rimas V. ;
Solomon, Isaac H. ;
Ligon, Keith L. ;
Nakashima, Hiroshi ;
Triggs, Daniel A. ;
Reardon, David A. ;
Wen, Patrick ;
Stopa, Brittany M. ;
Naik, Ajay ;
Rudnick, Jeremy ;
Hu, Jethro L. ;
Kumthekar, Priya ;
Yamini, Bakhtiar ;
Buck, Jill Y. ;
Demars, Nathan ;
Barrett, John A. ;
Gelb, Arnold B. ;
Zhou, John ;
Lebel, Francois ;
Cooper, Laurence J. N. .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (505)
[9]   Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses [J].
Cho, Jang Hwan ;
Collins, James J. ;
Wong, Wilson W. .
CELL, 2018, 173 (06) :1426-+
[10]   CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity [J].
Choi, Bryan D. ;
Yu, Xiaoling ;
Castano, Ana P. ;
Bouffard, Amanda A. ;
Schmidts, Andrea ;
Larson, Rebecca C. ;
Bailey, Stefanie R. ;
Boroughs, Angela C. ;
Frigault, Matthew J. ;
Leick, Mark B. ;
Scarfo, Irene ;
Cetrulo, Curtis L. ;
Demehri, Shadmehr ;
Nahed, Brian V. ;
Cahill, Daniel P. ;
Wakimoto, Hiroaki ;
Curry, William T. ;
Carter, Bob S. ;
Maus, Marcela V. .
NATURE BIOTECHNOLOGY, 2019, 37 (09) :1049-+